These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

597 related items for PubMed ID: 17450183

  • 21. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A, Olivé T, Martinez A, Bureo E, Maldonado MS, Diaz de Heredia C, Sastre A, Gonzalez-Vicent M, Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
    [Abstract] [Full Text] [Related]

  • 22. Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function.
    Okuda S, Terasako K, Oshima K, Sato M, Nakasone H, Kako S, Yamazaki R, Tanaka Y, Tanihara A, Higuchi T, Nishida J, Kanda Y.
    Am J Hematol; 2009 Mar; 84(3):167-9. PubMed ID: 19195036
    [Abstract] [Full Text] [Related]

  • 23. Allogeneic stem cell transplantation for severe aplastic anemia: graft rejection remains a problem.
    Aki SZ, Sucak GT, Ozkurt ZN, Yeğin ZA, Yağci M, Haznedar R.
    Transfus Apher Sci; 2009 Feb; 40(1):5-11. PubMed ID: 19121979
    [Abstract] [Full Text] [Related]

  • 24. Umbilical cord blood transplant for adult patients with severe aplastic anemia using anti-lymphocyte globulin and cyclophosphamide as conditioning therapy.
    Mao P, Wang S, Wang S, Zhu Z, Liv Q, Xuv Y, Mo W, Ying Y.
    Bone Marrow Transplant; 2004 Jan; 33(1):33-8. PubMed ID: 14704655
    [Abstract] [Full Text] [Related]

  • 25. Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India.
    Choudhary D, Sharma SK, Gupta N, Kharya G, Pavecha P, Handoo A, Setia R, Katewa S.
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):492-5. PubMed ID: 23160007
    [Abstract] [Full Text] [Related]

  • 26. Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens.
    Ruiz-Argüelles GJ, Gómez-Almaguer D, Ruiz-Argüelles A, González-Llano O, Cantú OG, Jaime-Pérez JC.
    Am J Hematol; 2001 Apr; 66(4):241-4. PubMed ID: 11279633
    [Abstract] [Full Text] [Related]

  • 27. Allogeneic hematopoietic stem cell transplantation is superior to immunosuppressive therapy in Indian children with aplastic anemia--a single-center analysis of 100 patients.
    George B, Mathews V, Viswabandya A, Lakshmi KM, Srivastava A, Chandy M.
    Pediatr Hematol Oncol; 2010 Mar; 27(2):122-31. PubMed ID: 20201693
    [Abstract] [Full Text] [Related]

  • 28. [Comparison of conditioning regimens containing or no fludarabine in nonmyeloablative allogeneic peripheral blood stem cell transplantation].
    Guo M, Yu CL, Wang DH, Qiao JH, Sun WJ, Shi BF, Zhang S, Sun QY, Yao B, Ai HS.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):413-5. PubMed ID: 14642178
    [Abstract] [Full Text] [Related]

  • 29. Fludarabine-based conditioning for allogeneic stem cell transplantation for multiply transfused patients with Fanconi's anemia.
    George B, Mathews V, Shaji RV, Srivastava V, Srivastava A, Chandy M.
    Bone Marrow Transplant; 2005 Feb; 35(4):341-3. PubMed ID: 15640819
    [Abstract] [Full Text] [Related]

  • 30. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors.
    de la Fuente J, Reiss S, McCloy M, Vulliamy T, Roberts IA, Rahemtulla A, Dokal I.
    Bone Marrow Transplant; 2003 Oct; 32(7):653-6. PubMed ID: 13130311
    [Abstract] [Full Text] [Related]

  • 31. The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells.
    Ayas M, Al-Seraihi A, El-Solh H, Al-Ahmari A, Khairy A, Aldali A, Markiz S, Siddiqui K, Al-Jefri A.
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):627-32. PubMed ID: 21871862
    [Abstract] [Full Text] [Related]

  • 32. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H, Ikegame K, Yoshihara S, Kawakami M, Fujioka T, Masuda T, Taniguchi Y, Hasei H, Kaida K, Inoue T, Kim EH, Kawase I.
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [Abstract] [Full Text] [Related]

  • 33. [Bone marrow transplantation for severe aplastic anemia].
    Bullorsky EO, Bonduel M, Shanley C, Figueroa C, Stemmelin G, Del Pozo A, Ceresetto J, Delfino S, Puppo M, Muriel FS.
    Medicina (B Aires); 1998 Oct; 58(2):130-4. PubMed ID: 9706244
    [Abstract] [Full Text] [Related]

  • 34. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
    Lee KH, Lee JH, Lee JH, Kim DY, Kim SH, Shin HJ, Lee YS, Kang YA, Seol M, Ryu SG.
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944
    [Abstract] [Full Text] [Related]

  • 35. A fludarabine-based conditioning regimen for severe aplastic anemia.
    Chan KW, Li CK, Worth LL, Chik KW, Jeha S, Shing MK, Yuen PM.
    Bone Marrow Transplant; 2001 Jan; 27(2):125-8. PubMed ID: 11281379
    [Abstract] [Full Text] [Related]

  • 36. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia.
    Azuma E, Kojima S, Kato K, Matsuyama T, Yamada Y, Kondo N, Sawada H, Hanada M, Shibata T, Tabata N, Watanabe M, Shimono Y, Deguchi T, Umemoto M, Higashikawa M, Kawasaki H, Komada Y, Sakurai M.
    Bone Marrow Transplant; 1997 Jun; 19(11):1085-7. PubMed ID: 9193750
    [Abstract] [Full Text] [Related]

  • 37. Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning.
    Uzunel M, Remberger M, Sairafi D, Hassan Z, Mattsson J, Omazic B, Barkholt L, Ringdén O.
    Transplantation; 2006 Oct 15; 82(7):913-9. PubMed ID: 17038906
    [Abstract] [Full Text] [Related]

  • 38. Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD.
    Novitzky N, Thomas V, du Toit C, McDonald A.
    Bone Marrow Transplant; 2009 May 15; 43(10):779-85. PubMed ID: 19079315
    [Abstract] [Full Text] [Related]

  • 39. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
    Koh LP, Chen CS, Tai BC, Hwang WY, Tan LK, Ng HY, Linn YC, Koh MB, Goh YT, Tan B, Lim S, Lee YM, Tan KW, Liu TC, Ng HJ, Loh YS, Mow BM, Tan DC, Tan PH.
    Biol Blood Marrow Transplant; 2007 Jul 15; 13(7):790-805. PubMed ID: 17580257
    [Abstract] [Full Text] [Related]

  • 40. Audit of peripheral stem cell transplantation for aplastic anemia in multitransfused infected patients.
    Seth T, Kanga U, Sood P, Sharma V, Mishra P, Mahapatra M.
    Transplant Proc; 2012 May 15; 44(4):922-4. PubMed ID: 22564586
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.